| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Aug 18, 2026 | Sell(S) | 400 | $2.01 | $804 | 53K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-26-003838) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for Acrivon Therapeutics, Inc.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.